Citadel Advisors »

Pharmacyte Biotech shares owned by Citadel Advisors

Quarter-by-quarter ownership of Pharmacyte Biotech (PMCB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Pharmacyte Biotech

Tip: Access up to 7 years of quarterly data

All positions including Pharmacyte Biotech held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pharmacyte Biotech by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $92k 42k 2.16
2023-09-30 $85k 40k 2.10
2023-06-30 $287k 100k 2.86
2023-03-31 $476k 163k 2.91
2022-12-31 $350k 120k 2.92
2022-06-30 $252k 111k 2.27
2022-03-31 $79k 35k 2.29
2021-12-31 $99k 39k 2.52
2021-09-30 $68k 21k 3.19